Patents by Inventor Norikazu SAKAKIBARA

Norikazu SAKAKIBARA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11571416
    Abstract: Described herein are pharmaceutical compositions capable of blocking entry of a virus into a host cell and containing one or more compounds of the general formula I or a pharmaceutically acceptable derivative thereof and methods of treatment or prophylactic administration of these pharmaceutical compositions to treat viral infections.
    Type: Grant
    Filed: April 13, 2018
    Date of Patent: February 7, 2023
    Assignee: Kagoshima University
    Inventors: Robert A. Davey, Yasuteru Sakurai, Masanori Baba, Norikazu Sakakibara
  • Patent number: 11001557
    Abstract: The present invention pertains to an antiviral drug for severe fever with thrombocytopenia syndrome, which contains a compound represented by formula (I) or a salt thereof, or a solvate of the compound or salt (In the formula, R1 and R2 are the same or different from each other, and each represents a substituted or unsubstituted C1-10 alkyl group, R1 and R2 may form a substituted or unsubstituted 5- or 6-member ring in conjunction with an adjacent nitrogen atom, and X represent a halogen atom.
    Type: Grant
    Filed: January 16, 2018
    Date of Patent: May 11, 2021
    Assignees: Kagoshima University, Nobelpharma Co., Ltd.
    Inventors: Masanori Baba, Masaaki Toyama, Norikazu Sakakibara
  • Publication number: 20200113891
    Abstract: Described herein are pharmaceutical compositions capable of blocking entry of a virus into a host cell and containing one or more compounds of the general formula I or a pharmaceutically acceptable derivative thereof and methods of treatment or prophylactic administration of these pharmaceutical compositions to treat viral infections.
    Type: Application
    Filed: April 13, 2018
    Publication date: April 16, 2020
    Inventors: Robert A. DAVEY, Yasuteru SAKURAI, Masanori BABA, Norikazu SAKAKIBARA
  • Publication number: 20190389803
    Abstract: The present invention pertains to an antiviral drug for severe fever with thrombocytopenia syndrome, which contains a compound represented by formula (I) or a salt thereof, or a solvate of the compound or salt (In the formula, R1 and R2 are the same or different from each other, and each represents a substituted or unsubstituted C1-10 alkyl group, R1 and R2 may form a substituted or unsubstituted 5- or 6-member ring in conjunction with an adjacent nitrogen atom, and X represent a halogen atom.
    Type: Application
    Filed: January 16, 2018
    Publication date: December 26, 2019
    Applicants: Kagoshima University, Nobelpharma Co., Ltd.
    Inventors: Masanori BABA, Masaaki TOYAMA, Norikazu SAKAKIBARA